Rare diseases
Investigational molecules
Locations
474 conditions with trials, the busiest first
1 133 trials across Europe, recruiting first
AustriaStudy of ZN-c3, Encorafenib, and Cetuximab for Adults with Metastatic Colorectal Cancer
GermanyStudy of Subcutaneous Nivolumab with or without Recombinant Human Hyaluronidase PH20 for Patients with Lung, Kidney, Melanoma, Liver, Colorectal, or Bladder Cancer
FranceStudy on Early vs. Delayed Supplementary Parenteral Nutrition with SmofKabiven for Patients After Major Emergency Abdominal Surgery
DenmarkStudy of Orismilast for Treating Moderate to Severe Ulcerative Colitis in Adults
DenmarkStudy on the Effectiveness and Safety of Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells for Treating Complex Perianal Fistulas in Children with Crohn's Disease
The NetherlandsStudy on the Tolerability and Effectiveness of Tirbanibulin for Patients with Actinic Cheilitis
GermanyStudy on the Safety and Effectiveness of ABBV-668 for Adults with Moderate to Severe Ulcerative Colitis
BelgiumStudy on the Effectiveness and Safety of Pembrolizumab, Lenvatinib, and Chemotherapy for Patients with Metastatic Esophageal Cancer
DenmarkStudy on the Effectiveness of Ompenaclid with FOLFIRI and Bevacizumab for Patients with Advanced or Metastatic Colorectal Cancer
BelgiumStudy on the Safety of Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells for Treating Inflammatory Bowel Strictures in Crohn's Disease Patients
SpainStudy of DKN-01 and Tislelizumab with Chemotherapy for Adults with Advanced Gastric or Gastroesophageal Cancer
GermanyThe therapies tested most often in Gastrointestinal disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
